000 01076 a2200289 4500
005 20250512205646.0
264 0 _c19830923
008 198309s 0 0 eng d
022 _a0360-3016
024 7 _a10.1016/0360-3016(83)90194-3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDenekamp, J
245 0 0 _aIs the outlook grey for WR-2721 as a clinical radioprotector?
_h[electronic resource]
260 _bInternational journal of radiation oncology, biology, physics
_cAug 1983
300 _a1247-9 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aAmifostine
_xtherapeutic use
650 0 4 _aAnimals
650 0 4 _aHumans
650 0 4 _aNeoplasms
_xradiotherapy
650 0 4 _aOrganothiophosphorus Compounds
_xtherapeutic use
650 0 4 _aRadiation-Protective Agents
_xtherapeutic use
700 1 _aStewart, F A
700 1 _aRojas, A
773 0 _tInternational journal of radiation oncology, biology, physics
_gvol. 9
_gno. 8
_gp. 1247-9
856 4 0 _uhttps://doi.org/10.1016/0360-3016(83)90194-3
_zAvailable from publisher's website
999 _c6307866
_d6307866